New research reveals that people who discontinue popular weight-loss injections like semaglutide or tirzepatide tend to recover reduced body mass far faster than those who end conventional lifestyle programs.
Findings released in a leading medical journal points out that while overweight people frequently drop about a fifth of their body weight while using the jabs, the mass comes back at an estimated rate of 0.8 kg per month after stopping.
"Users buying these treatments must be cognizant of the risk of quick rebound weight gain when the therapy ends," stated researcher Dr. Susan Jebb.
This pace of recovery implies a return to pre-treatment mass within about 18 months.
Weighing Approaches
The research, which looked at dozens of trials involving over 9,000 of patients, contrasted the effects of these new drugs with other pills.
The team point out that individuals who shed pounds through dieting generally experience a less rapid weight regain—around 0.1 kg a month—after stopping.
Understanding the Rapid Regain
Experts suggest the way of the jabs accounts for the amplified rebound.
The injections mimic a body's own chemical called GLP-1, which helps regulate hunger.
"Long-term administration of GLP-1 levels far above than normal could lead to the system to produce less of its own natural hormone, and could diminish sensitivity to its effects," noted Dr. Adam Collins, a nutrition specialist.
"Discontinuation of this medication leads to hunger is no longer kept in check, making overeating far more likely."
A Chronic Disease?
Health authorities recommend the jabs for individuals with obesity-related medical conditions, accompanied by recommended lifestyle changes.
Many experts contend that, due to the high risk of relapse, the treatment should be considered long-term.
This view is supported by pharmaceutical companies, who say that the findings "emphasize the persistent character of excess weight," similar to managing diseases like high blood pressure.
Patient Testimonies
People who have come off the jabs explain a intense return of appetite.
"It felt as if a trigger flipping and I was suddenly extremely hungry," described an individual.
This challenge is worsened if patients have not established permanent dietary or behavioural changes during treatment.
Growing Interest
Figures show that a significant number of adults in the UK have used these injections in the last 12 months, with demand continuing to grow.
- Adoption is higher among females than men.
- The middle-aged demographic shows the highest usage rates.
- Many access the drugs through private healthcare rather than public health services.
Ultimately, experts emphasize that while these medications are potent agents for weight loss, they are not a permanent cure and lasting health benefits hinges on integrated lifestyle changes.
